At the Tribunal | |
Before
MR RECORDER LANGSTAFF QC
MR D CHADWICK
MS J DRAKE
APPELLANT | |
RESPONDENT |
Transcript of Proceedings
PRELIMINARY HEARING
EAT/1404/01/MAA
For the Appellant | MR S J HOYLE (Representative) |
MR RECORDER LANGSTAFF QC:-
"The Panel have noted the time which elapsed between the issuing of a written warning in September 1998, because of problems relating to attitude, and you commencing to take medication in December 1998. The Panel feel that no evidence was provided to the Disciplinary Hearing about your medical condition or the alleged side effects of the prescribed medication and that the onus of responsibility was on you to make the Trust aware of the implications."
By the time the matter came before the Employment Tribunal it was established on medical evidence, which had not been before the employer, that Mr Toon had suffered from an acute stress reaction leading to depression which had probably been caused by his taking a drug to counteract his dermatitis, a drug called Roaccutane.
"No evidence of the side effects of Roaccutane was presented."
If one takes that sentence in isolation and at face value, it is certainly wrong or at least misleading. This is because, as Mr Hoyle has pointed out to us, there are a number of findings of fact by the Tribunal which show that the panel did indeed have brought to its notice the fact that Mr Toon had been suffering from illness and that it was alleged that that illness was in consequence of the side effects of Roaccutane. In particular, he has directed our attention to paragraph 4 (o) in which it is recorded by the Tribunal that at the first hearing the representative for Mr Toon had stated that he was taking a drug called Roaccutane and that the side effects of that were mood swings and mood changes, that he was taking anti-depressants and was seeing a counsellor. He has added to that what is noted at paragraph 4 (q) when at the appeal hearing a different representative for Mr Toon had explained that the applicant was taking Roaccutane and referred to its side effects of mood swings and depression. He has told us a matter which is not recorded in the decision but which for the purposes of these submissions we accept as having happened, which is that Mr Hinchley has accepted that he was shown an entry in the British National Formulary which referred to the known side effects of Roaccutane as including mood swings and depression. On that basis, he submits, that there was no evidential basis for the Tribunal reaching a conclusion which taken at face value appears to contradict the earlier findings.
It is plain that that document indicates that the issue of side effects had been raised, but what was being referred to was not the suggestion that the behaviour of Mr Toon might be due to the drugs but the absence of responsible medical opinion which would actually link the known side effects of Roaccutane, in some circumstances and in some individuals, to this individual in these circumstances in respect of this conduct.